Cytel · 10 hours ago
Principal Quantitative Clinical Pharmacologist - FSP
United States
Full-time
Remote
Lead/StaffCytel is a leading company in the field of clinical development and analysis, and they are seeking a Principal Quantitative Clinical Pharmacologist to lead quantitative pharmacology activities for clinical studies. This role involves contributing to Pop-PK and PK/PD modeling, study design, and collaboration with cross-functional teams to support clinical trials for a global pharmaceutical client.
ConsultingSoftware
Responsibilities
Contribute to Pop-PK and PK/PD modeling, and non-compartmental analyses
Contribute to study design, including Bayesian/adaptive design methodologies
Create specifications and perform analyses such as time-to-event and longitudinal analysis
Review and contribute to study reports and quantitative clinical pharmacology sections of regulatory submission dossiers, lead electronic submissions of clinical data to regulatory authorities, and participate to meetings with regulatory authorities
Develop strong collaboration and communication with sponsor cross-functional teams and sponsor Biostatistics management
Qualification
Required
Experience in Pop-PK and PK/PD modelling, and non-compartmental analyses
Understanding of the broader biopharmaceutical R&D process
Excellent organization and multi-tasking capabilities, strong problem-solving and analytical skills
Experienced in Phoenix WinNonLin and NLME, and R
Company
Cytel
Our mission is to improve success rates in this endeavor via the optimal design, effective implementation
Founded in 1987
1001-5000 employees
H1B Sponsorship
Cytel has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (38)
2024 (54)
2023 (37)
2022 (46)
2021 (43)
2020 (33)
Funding
Current Stage
Late StageTotal Funding
$2MKey Investors
New Mountain CapitalMerck Capital Ventures
2021-01-01Series Unknown
2020-12-21Acquired
2017-11-01Private Equity
Leadership Team
Cyrus Mehta
Co-Founder and President
Nitin Patel
Chairman and Chief Technology Officer
Recent News
Adial Pharmaceuticals, Inc
2025-08-14
2025-06-11
Company data provided by crunchbase